| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Lineage Cell Therapeutics, Inc. | Chairman, Director | Common Shares, no par value | 5,430,545 | $5,919,294 | $1.09 | 01 Dec 2022 | Direct |
| Lineage Cell Therapeutics, Inc. | Chairman, Director | Common Shares, no par value | 1,043,346 | $1,137,247 | $1.09 | 31 Dec 2022 | By Corporation |
| Lineage Cell Therapeutics, Inc. | Chairman, Director | Common Shares, no par value | 375,351 | $409,133 | $1.09 | 31 Dec 2022 | By LP |
| Oncocyte Corp | Director | Common Stock, no par value | 489,111 | $105,110 | $0.2149 | 23 Jun 2023 | Direct |
| Oncocyte Corp | Director | Common Stock, no par value | 18,767 | $4,033 | $0.2149 | 23 Jun 2023 | Indirect |
| Oncocyte Corp | Director | Option to Purchase Common Stock | 90,000 | 23 Jun 2023 | Direct | ||
| Lineage Cell Therapeutics, Inc. | Chairman, Director | Stock Option (Right to Buy) | 50,000 | 01 Jul 2023 | Direct | ||
| Oncocyte Corp | Director | Restricted Stock Units | 0 | 24 Jun 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2023 | 1 | $0 | 4 | Chairman, Director | 03 Jul 2023, 17:46 |
| OCX | Oncocyte Corp | 23 Jun 2023 | 2 | $0 | 4 | Director | 27 Jun 2023, 21:30 |
| OCX | Oncocyte Corp | 14 Jun 2023 | 1 | +$6,447 | 4 | Director | 15 Jun 2023, 20:13 |
| LCTX | Lineage Cell Therapeutics, Inc. | 31 Dec 2022 | 1 | $0 | 5 | Director | 14 Feb 2023, 15:16 |
| OCX | Oncocyte Corp | 22 Dec 2022 | 1 | +$7,125 | 4 | Director | 27 Dec 2022, 17:47 |
| OCX | Oncocyte Corp | 15 Aug 2022 | 4 | +$9,700 | 4 | Director | 17 Aug 2022, 20:20 |
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2022 | 1 | $0 | 4 | Director | 06 Jul 2022, 16:15 |
| OCX | Oncocyte Corp | 24 Jun 2022 | 2 | $0 | 4 | Director | 19 Jul 2022, 16:05 |
| LCTX | Lineage Cell Therapeutics, Inc. | 31 Dec 2021 | 1 | $0 | 5 | Director | 11 Feb 2022, 15:15 |
| LCTX | Lineage Cell Therapeutics, Inc. | 01 Jul 2021 | 1 | $0 | 4 | Director | 01 Jul 2021, 18:21 |
| OCX | OncoCyte Corp | 24 Jun 2021 | 2 | $0 | 4 | Director | 28 Jun 2021, 20:32 |
| LCTX | Lineage Cell Therapeutics, Inc. | 22 Jun 2021 | 2 | +$135,960 | 4 | Director | 23 Jun 2021, 13:15 |